Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2019, Article ID 7083491, 10 pages
https://doi.org/10.1155/2019/7083491
Research Article

Lipid-Rich Extract from Mexican Avocado Seed (Persea americana var. drymifolia) Reduces Staphylococcus aureus Internalization and Regulates Innate Immune Response in Bovine Mammary Epithelial Cells

1Centro Multidisciplinario de Estudios en Biotecnología-FMVZ, Universidad Michoacana de San Nicolás de Hidalgo, Km 9.5 Carretera Morelia-Zinapécuaro, Posta Veterinaria C.P., 58893 Morelia, Michoacán, Mexico
2Departamento de Biología, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Mexico
3Instituto de Investigaciones Químico Biológicas, UMSNH. Ciudad Universitaria, Morelia, Michoacán, Mexico

Correspondence should be addressed to Joel Edmundo López-Meza; xm.hcimu@azemle

Received 20 May 2019; Accepted 23 August 2019; Published 12 September 2019

Guest Editor: Yanyan Qu

Copyright © 2019 Marisol Báez-Magaña et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Bovine mammary epithelial cells (bMECs) are capable of initiating an innate immune response (IIR) to invading bacteria. Staphylococcus aureus is not classically an intracellular pathogen, although it has been shown to be internalized into bMECs. S. aureus internalizes into nonprofessional phagocytes, which allows the evasion of the IIR and turns antimicrobial therapy unsuccessful. An alternative treatment to control this pathogen is the modulation of the innate immune response of the host. The Mexican avocado (Persea americana var. drymifolia) is a source of molecules with anti-inflammatory and immunomodulatory properties. Hence, we analyze the effect of a lipid-rich extract from avocado seed (LEAS) on S. aureus internalization into bMECs and their innate immunity response. The effects of LEAS (1-500 ng/ml) on the S. aureus growth and bMEC viability were assessed by turbidimetry and MTT assays, respectively. LEAS did not show neither antimicrobial nor cytotoxic effects. S. aureus internalization into bMECs was analyzed by gentamicin protection assays. Interestingly, LEAS (1-200 ng/ml) decreased bacterial internalization (60-80%) into bMECs. This effect correlated with NO production and the induction of the gene expression of IL-10, while the expression of the proinflammatory cytokine TNF-α was reduced. These effects could be related to the inhibition of MAPK p38 (∼60%) activation by LEAS. In conclusion, our results showed that LEAS inhibits the S. aureus internalization into bMECs and modulates the IIR, which indicates that avocado is a source of metabolites for control of mastitis pathogens.

1. Introduction

The innate immune response (IIR) is the first line of defense of organisms, which has a relevant role in the protection against pathogens. The participation of professional phagocytic cells (c.a. macrophages, dendritic cells, and circulating leukocytes) in the IIR is fundamental; however, nonprofessional phagocytic cells (c.a. epithelium, endothelium, osteoblast, and fibroblast cells) also have a relevant role [1]. In this sense, bovine mammary epithelial cells (bMECs) play an important role in the IIR of the mammary gland acting as a physical barrier and as initial sensors of danger with the capacity to mount a defense response [2]. The IIR regulation by immunomodulatory molecules such as fatty acids and vitamins has been widely demonstrated and involves epigenetics changes that can be stably maintained or adapted to changing environments [3, 4]. For the above, the search for modulators that improve the bMEC IIR increases the opportunity to identify novel therapeutics.

S. aureus is the main pathogen responsible for subclinical bovine mastitis, a chronic and recurrent disease that affect dairy cattle worldwide [5, 6]. This bacterium has the ability to be internalized into the cells, which allows it to evade the IIR of the host; this characteristic has been associated with the recurrence of mastitis [7, 8]. In previous reports, we showed that immunomodulatory molecules (short and medium chain fatty acids, and cholecalciferol) inhibit S. aureus internalization into bMECs regulating the IIR, suggesting an immunomodulatory role in host-pathogen interaction [3, 8, 9].

For a long time, plants have been a rich source of antibacterial, antiviral, and immunomodulatory metabolites. In this sense, avocado (Persea americana) is a very nutritious fruit (rich in saturated and unsaturated fatty acids) that possesses different compounds with antioxidant, anticancer, antimicrobial, and anti-inflammatory properties [10]. Diverse reports have shown that avocado metabolites have immunomodulatory properties. For example, an avocado/soybean unsaponifiable (ASU) mixture decreased the expression of TNF-α, IL-1β, COX-2, and iNOS in bovine chondrocytes and human monocyte/macrophages [11, 12]. Likewise, seven-carbon sugars typical of avocado (mannoheptulose and perseitol) inhibited Malassezia furfur internalization into human keratinocytes and induced expression of the antimicrobial peptide HBD-2 [13]. Also, avocado aliphatic acetogenins (lipid derivative molecules present in mesocarp and endocarp) favored the apoptosis induction and cell cycle arrest in different human cancer cell lines [14, 15]. Furthermore, the anti-inflammatory and photoprotective effects of polyhydroxylated fatty alcohols (synonymous of acetogenins) extracted from Persea gratissima on human keratinocytes damaged by UV have been demonstrated [16]. However, it is unknown if lipid derivative molecules from Mexican avocado seed (Persea americana var. drymifolia) display immunomodulatory properties in host-pathogen interaction. Thus, in this work, we analyzed the effects of a lipid-rich extract from Mexican avocado seed (LEAS) on S. aureus internalization into bMECs. In addition, the effects of LEAS on the IIR of bMECs were analyzed.

2. Materials and Methods

2.1. Lipid-Rich Extract from Avocado Seed (LEAS)

Mexican avocado fruits (Persea americana var. drymifolia) used in this study were collected when physiological maturity was achieved. The LEAS was obtained according to Rosenblat et al. [16]. Briefly, avocado seeds were separated from the fruit and frozen in liquid nitrogen, followed by trituration. The powder obtained was extracted with hexane (C6H14, J.T. Baker) for 14 h in a Soxhlet apparatus. This lipid-rich fraction was filtered and then cooled to -18°C overnight for a cold crystallization. Precipitated crystals were recovered discarding the supernatant and then drying with nitrogen gas. This extract contains abundant molecules of 16-24 carbon aliphatic chains with hydroxyl groups such as aliphatic acetogenins and long-chain fatty acids as determined by gas chromatography-mass spectrometry (GC-MS) (Table 1). For biological assays, crystals were resuspended in dimethyl sulfoxide (DMSO 5%). In all of the experiments, the final concentration of DMSO was 0.1%.

Table 1: Composition of lipid-rich extract from Mexican avocado seed (Persea americana var. drymifolia).
2.2. Staphylococcus aureus Strain

The S. aureus subsp. aureus (ATCC27543) strain was used in this study. The strain was isolated from a case of bovine mastitis that has the capability to internalize into bMECs [3]. Bacteria were grown overnight in Luria-Bertani (LB) broth (Bioxon, México). For the different assays, the colony-forming units (CFU) were adjusted by measuring their optical density at 590 nm (OD ).

2.3. Primary Culture Bovine Mammary Epithelial Cells (bMECs)

bMECs were isolated of alveolar tissue from the udder of a healthy lactating cow as described [17]. Cells from passages 2-8 were used in all of the experiments. The bMECs were cultured in growth medium (GM) that was composed of DMEM medium/nutrient mixture F12 Ham (DMEM/F12, Sigma) supplemented with 10% fetal bovine serum (Biowest), 10 μg/ml insulin (Sigma), 5 mg/ml hydrocortisone (Sigma), 100 U/ml penicillin, 100 μg/ml streptomycin, and 1 μg/ml amphotericin B (Sigma). The cells were grown in a 5% CO2 atmosphere at 37°C.

2.4. Effect of Lipid-Rich Extract from Avocado Seed on S. aureus 27543 Growth and bMEC Viability

The effect of LEAS on S. aureus growth was determined by turbidimetry assay. For this, was cultured at 37°C in LB broth supplemented with different concentrations of LEAS (1-500 ng/ml) and growth was monitored turbidimetrically (590 nm) at 2, 6, 12, and 24 h.

To analyze the effect of LEAS on bMEC viability, cells were incubated with the extract (1-500 ng/ml) during 24-48 h at 37°C in 96-well flat-bottom plates in GM without supplements. Further, cells were detached with trypsin-EDTA (Sigma) and resuspended in a 1 : 1 dilution with 0.4% Trypan blue solution (Sigma) and incubated for 3 minutes. Finally, nonviable and viable cells were counted in a hemocytometer.

2.5. Effect of Lipid-Rich Extract from Avocado Seed on S. aureus 27543 Adhesion and Internalization into bMECs

Gentamicin protection assay was carried out using bMECs monolayers ( cells) cultured in 24-well dishes treated with 6-10 μg/cm2 rat tail type I collagen (Sigma) as described [3]. bMECs were incubated with different concentrations of LEAS (1-200 ng/ml) in DMEM/F12 media (Sigma) without supplements for 24 h followed by S. aureus infection (MOI 30 : 1 bacteria per cell). For this, the bMECs were inoculated with bacterial suspensions () and incubated for 2 h in 5% CO2 at 37°C. Afterward, bMECs were washed three times with PBS (pH 7.4) and incubated with DMEM medium supplemented with 80 μg/ml gentamicin for 1 h at 37°C to eliminate extracellular bacteria. Finally, bMEC monolayers were detached with trypsin EDTA (Sigma) and lysed with 250 μl of sterile distilled water. bMEC lysates were diluted 100-fold and plated on LB agar, and Petri dishes were incubated overnight at 37°C. The number of CFUs was determined by the standard colony counting technique. Data are presented as the percentage of internalization in relation to control (bMECs treated with vehicle).

To determine the adhesion of S. aureus on bMECs, cells were cultured and treated as described above but the gentamicin treatment was omitted. Data are presented as the percentage of adhesion in relation to control (bMECs treated with vehicle).

2.6. Staphylococcus aureus Viability in bMEC-Conditioned Media

To evaluate S. aureus survival in conditioned media, bMECs were cultured ( cells) in 24-well plates with 6-10 μg/cm2 rat tail type I collagen (Sigma). Then, bMECs were treated with LEAS (100 ng/ml) for 24 h and the culture medium was recovered. Next, conditioned media were inoculated with S. aureus suspension () and incubated for 2 h at 37°C and 180 rpm. Finally, a dilution of this suspension (1 : 1000) was plated on LB agar and incubated overnight at 37°C. The number of CFUs was determined by the standard colony counting technique.

2.7. Effects of Lipid-Rich Extract from Avocado Seed on MAP Kinase Activation in bMECs

The evaluation of the MAP kinase activation (p38, JNK, or ERK1/2) was carried out as reported [18]. Briefly, bMEC monolayers were cultivated on 96-well flat-bottom plates that were coated (Corning-Costar) with 6-10 μg/cm2 rat tail type I collagen (Sigma). MAP kinase activation levels were assessed by flow cytometry in bMECs pretreated with LEAS (100 ng/ml, 24 h). pp38 (T180/Y182), pJNK1/2 (T183/185), and pERK1/2 (T202/Y204) were quantitatively determined using a Flex Set Cytometric Bead Array (Becton Dickinson) according to the manufacturer’s protocol using a BD Accuri™ C6 flow cytometer. Data were analyzed with FCAP software (Becton Dickinson). A total of 3000 events were acquired following the supplied protocol. The minimum detection levels for each phosphoprotein were 0.38 U/ml for pJNK and 0.64 U/ml for pp38 and pERK. The corroboration of MAPK activation was performed using different inhibitors (data not shown).

2.8. RNA Isolation and Innate Immune Response Gene Expression Analysis

To analyze the effects of LEAS and/or S. aureus on the expression of IIR genes of bMECs, monolayers of cells cultured in 6-well plates with 6-10 μg/cm2 rat tail type I collagen (Sigma) were incubated with LEAS 100 ng/ml (24 h) and/or S. aureus for 2 h (MOI 30 : 1). bMEC total RNA (5 μg) was extracted with the TRIzol reagent (Invitrogen) according to the manufacturer’s instructions. Genomic DNA contamination was removed from RNA samples with DNase I treatment (Invitrogen). Then, cDNA was synthesized as described [19]. The relative quantification of gene expression (qPCR) was performed using the comparative method () in a StepOne Plus Real-Time PCR System (Applied Biosystems) according to the manufacturer’s instructions. The reactions were carried out with VeriQuest SYBR Green qPCR Master Mix (Affymetrix). Specific primer pairs were acquired from Invitrogen and Elim Biopharm (Table 2), and their specificity was determined by endpoint PCR. The GAPDH gene was used as an internal control.

Table 2: Bovine oligonucleotides used in this study.

For the measurement of the TNF-α and IL-1β concentrations in the conditioned medium, bMECs were treated with LEAS (100 ng/ml) and/or S. aureus. The concentrations of TNF-α were measured using the DuoSet ELISA Development Kit (R&D Systems) according to the manufacturer’s instructions, and the concentrations of IL-1β were assessed using the bovine IL-1β screening kit (Thermo Scientific).

2.9. Determination of Nitric Oxide (NO) and Reactive Oxygen Species (ROS)

Nitric oxide was estimated by Griess reaction. For this, bMECs were cultured ( cells) in 24-well plates with 6-10 μg/cm2 rat tail type I collagen (Sigma). Then, bMECs were treated with LEAS (100 ng/ml) for 24 h. After treatment, the cells were infected with S. aureus (2 h) and the conditioned medium was recovered. The NO secreted by bMECs into culture medium was evaluated by measuring the nitrite concentration (NO2-) in cell-free media using the Griess reaction as described [3].

To analyze the production of ROS, the method of Tarpey and Fridovich [20] was used. For this, bMECs ( cells) were grown in 24-well plates (Corning Costar) until 80% of confluence. Afterward, the LEAS (100 ng/ml) was added for 24 h; then, bMECs were infected with S. aureus (2 h). Subsequently, bMECs were detached with trypsin, recovered, and washed with PBS by centrifugation and the supernatant was removed. bMECs were incubated for 30 minutes with dihydrorhodamine-123 (DHR) 5 mM (Molecular Probes). ROS were determined by flow cytometry (BD Accuri™ C6 flow cytometer). In both evaluations, LPS was used as a positive control.

2.10. Data Analysis

The data were obtained from three independent experiments; each one was performed in triplicate and compared with one-way analysis of mean comparisons using Student’s -test, except for ELISA; in this case, a one-way analysis of variance (one-way ANOVA) using the Tukey-Kramer test was used. The results are reported as the standard errors (SE), and the significance level was set at , except for RT-qPCR analysis where fold change values greater than 2 or less than 0.5 were considered as significant differentially expressed mRNAs [18]. The data were normalized to vehicle (DMSO 0.1%).

3. Results

3.1. The Lipid-Rich Extract from Avocado Seed Does Not Affect S. aureus Growth and bMEC Viability

To evaluate the effect of LEAS on S. aureus growth, bacteria were cultivated in LB broth supplemented with different concentrations (1-500 ng/ml). The turbidimetric results showed that the S. aureus growth was not affected by LEAS at the times evaluated (Figure 1(a)). In the same way, the effect of LEAS on the viability of bMECs was evaluated at 24 and 48 h using the Trypan blue exclusion assay. Data showed that LEAS did not affect bMEC viability at any concentration tested (Figure 1(b)).

Figure 1: The lipid-rich avocado seed extract did not affect S. aureus growth and bMECs viability. (a) S. aureus was grown in LB at 37°C (18 h). The OD590 was adjusted at 0.2 ( CFU) and the treatments were added. The growth was monitored measuring the OD at the indicated time. (b) bMECs were grown in 96-well dishes (80% confluence) and the treatments were added. The viability was determined by Trypan blue exclusion assay at 24 and 48 h. The results correspond to three independent experiments performed by triplicate. Vehicle (DMSO 0.1%) (, Student’s -test).
3.2. The Lipid-Rich Extract from Avocado Seed Inhibits the S. aureus Internalization into bMECs

The effect of LEAS on S. aureus internalization into bMECs was evaluated by gentamicin protection assay. bMECs were treated with LEAS (1-200 ng/ml) 24 h before bacterial challenge. According to the CFUs recovered, the LEAS (1-200 ng/ml) significantly decreased S. aureus internalization into bMECs (60-80%) in all of the concentrations tested in relation to vehicle (Figure 2(a)). The more pronounced inhibitory effect was observed at 100 ng/ml (80%). Interestingly, this concentration also decreased the S. aureus adhesion to bMECs (~30%) (Figure 2(b)). According to these results, we used this concentration in the rest of the experiments.

Figure 2: The lipid-rich avocado seed extract inhibits S. aureus internalization into bMECs and the adhesion. (a) The effect of LEAS on the internalization of S. aureus into bMECs is presented as the percentage of CFU recovered after the lysis of bMECs. The values were determined considering the vehicle (DMSO 0.1%) as 100% of internalization. The results are the average of three independent experiments performed in triplicate. Vehicle (DMSO 0.1%). indicates significant changes (, Student’s -test). (b) To determine the adhesion of S. aureus on bMECs, cells were cultured and treated as described in Materials and Methods but the gentamicin treatment was omitted. Data are presented as the percentage of adhesion in relation to control (bMECs treated with vehicle). indicates significant changes (, Student’s -test).
3.3. The Lipid-Rich Extract from Avocado Seed Improves the Defense of bMECs

In order to evaluate if the inhibitory effect of LEAS on S. aureus internalization into bMECs was related to the secretion of antimicrobial products by bMECs, we evaluated bacterial viability in the presence of conditioned media (culture media of bMECs treated 24 h with LEAS). Interestingly, bacterial viability diminished by ~30% in the presence of conditioned media, which suggests that LEAS induced the production and secretion of antimicrobial molecules in bMECs (Figure 3(a)).

Figure 3: The conditioned media of LEAS-pretreated bMECs showed antimicrobial activity against S. aureus. (a) Effect of conditioned medium from bMECs treated with vehicle (DMSO 0.1%) or LEAS (100 ng/ml) for 24 h on S. aureus viability. Bacteria were incubated 2 h with conditioned media. The number of CFU recovered is shown. The results are the average of three independent experiments performed in triplicate. Vehicle (DMSO 0.1%). indicates significant changes (, Student’s -test). (b) Nitric oxide and (c) ROS production in bMECs treated with 100 ng/ml of LEAS for 24 h and then challenged with S. aureus for 2 h. NO production was measured as NO2- concentration in culture medium. ROS production was evaluated by flow cytometry. In (b, c), cells stimulated with LPS (1 μg/ml, 24 h) were used as a positive control. Each bar shows the mean of of three independent experiments. indicates significant changes (, Student’s -test) within the treatment. Vehicle (DMSO 0.1%).

Then, we evaluate if reactive oxygen and nitrogen species could contribute to the antimicrobial effect showed by the conditioned media. The results showed that bMECs treated with LEAS (100 ng/ml) for 24 h increased the NO levels; this effect was maintained even in bMECs challenged with S. aureus (Figure 3(b)). However, the ROS production was not affected by LEAS treatment (Figure 3(c)). These results suggest that NO production could be involved in the antimicrobial effect detected in the conditioned media.

3.4. The Lipid-Rich Extract from Avocado Seed Inhibits p38 but Not JNK1/2 or ERK1/2 in bMECs

MAPK activation has been involved in S. aureus internalization into bMECs [18]. Thus, we evaluated whether LEAS regulates MAPK activation (p38, JNK, or ERK1/2) in bMECs. Interestingly, in LEAS-pretreated bMECs the basal activation of JNK and ERK1/2 was not modified; however, phosphorylated p38 was diminished by ∼60% (Figure 4).

Figure 4: p38, JNK, and ERK1/2 activation regulated by LEAS in bMECs. MAPK phosphorylation was measured in bMECs that were treated with LEAS (100 ng/ml) by flow cytometry. Each bar shows the result of one experiment and a total of 3000 events were acquired. indicates significant changes (, Student’s -test) within the treatment. Vehicle (DMSO 0.1%).
3.5. The Lipid-Rich Extract from Avocado Seed Regulates the Expression of Innate Immune Elements in bMECs

bMECs are key elements of IIR and play a significant role in the defense against pathogens. Consequently, we analyzed the mRNA levels of the proinflammatory cytokines TNF-α, IL-1β, and IL-6 and the anti-inflammatory cytokine IL-10, as well as the antimicrobial peptides TAP, DEFB1, and BNBD5 in LEAS-pretreated bMECs before and after infection. LEAS favors an anti-inflammatory response in bMECs due to the decrease in the mRNA levels of the proinflammatory cytokine TNF-α (~0.5-fold) and the increase of IL-10 mRNA levels significantly (~11-fold). Notably, the effect on IL-10 was more pronounced in bMECs challenged with S. aureus (~22-fold) (Table 3). Furthermore, LEAS kept the reduction of the TNF-α secretion in the infected bMECs. Only the secretion of IL-1β was increased (~1.5-fold) when the LEAS-treated cells were infected with S. aureus (Table 4). Also, the mRNA levels for IL-1β and IL-6 were not modified for any of the conditions evaluated. In addition, we evaluated the mRNA levels of the antimicrobial peptides BNBD5, DEFB-1, and TAP. The treatment of bMECs with LEAS did not affect the mRNA expression of the antimicrobial peptides tested; however, the challenge with the bacteria increased the BNBD5 expression (~4-fold).

Table 3: Effect of lipid-rich extract from avocado seed on expression of innate immune elements of bMECs.
Table 4: Effect of lipid-rich extract from avocado seed on secretion of cytokines in bMECs.

4. Discussion

IIR modulation is an alternative for therapeutic or prophylactic treatment to control and prevent diseases. Previously, we showed that short- and medium-chain fatty acids reduced S. aureus internalization into bMECs and improved IIR [3, 8]. In this sense, avocado (a fruit rich in fatty acids) is attractive in the search of plant compounds with immunomodulatory properties. This work demonstrates that a lipid-rich extract from Mexican avocado seed reduced S. aureus internalization into bMECs and regulated the IIR.

Long-chain fatty acids have antimicrobial activity against S. aureus [21]. Oleic acid and lauric acid (>70 μg/ml) have showed antimicrobial effects against methicillin-resistant S. aureus [22]. Also, eicosapentaenoic acid and docosahexaenoic acid (128-256 mg/ml) have antimicrobial effects against S. aureus isolates from diverse origins, including isolates methicillin and vancomycin resistant [23]. Likewise, docosahexaenoic acid (30 μM) induces apoptosis in breast cancer cell lines MCF-7 and SK-BR-3 [24]. Avocado seed extract is rich in fatty acids (mainly palmitic, oleic, and linoleic), and derivatives such as acetogenins, avocatins, persins, pahuatins, or fatty acid alcohols have antimicrobial and cytotoxic activities [14, 25]. Noteworthy, LEAS (1-500 ng/ml) did not affect the S. aureus growth and bMEC viability (Figure 1). It is important to notice that the concentrations used in this work are lower than those reported with antibacterial and cytotoxicity properties. However, preliminary results of our group indicate that LEAS are cytotoxic to cancer cells (Caco-2) at concentrations above of 10 μg/ml (data unpublished).

Bacterial adhesion and internalization are important for the establishment of chronic bovine mastitis and thus are an attractive target in the implementation of strategies for its control. In a previous work, we demonstrated that pretreated bMECs with short- and medium-chain fatty acids showed a reduced S. aureus internalization. Sodium propionate (1-5 mM) decreased bacterial invasion by ~65%, whereas sodium butyrate (0.25 mM) inhibited it by ~50% [3]. Likewise, sodium hexanoate (0.25-5 mM) reduced S. aureus internalization by ~60% [26]. Similarly, LEAS inhibited S. aureus internalization into bMECs but its effect was more pronounced than those reported for short- and medium-chain fatty acids, reaching inhibition of 80% (Figure 2). Also, the inhibitory LEAS concentrations were lower suggesting a better effect of lipids from avocado seed. Additionally, LEAS diminished the S. aureus adhesion to bMECs (~30%), which partially explains the inhibited internalization by LEAS. Interestingly, in LEAS-pretreated bMECs, the levels of NO in conditioned media were increased and bacteria viability was reduced by ~30% when incubated with it (Figure 3(a)). This data suggests a participation of antimicrobial molecules in the reduction of bacterial internalization. This result agrees with a previous report, in which the inhibitory effect of estradiol on S. aureus internalization into bMECs was associated to the secretion of elements with antimicrobial activity in the conditioned media [27]. In the same way, de Lima et al. [28] reported that the NO production of macrophages was stimulated by fatty acids in a concentration-dependent manner; low concentrations (1-10 μM) stimulated NO production in J774 cells (murine macrophages), whereas high concentrations (50-200 μM) inhibited NO production. This data supports the fact that IIR of bMECs can be improved by immunomodulatory molecules which leads to the secretion of antimicrobial molecules that could contribute to the reduction in bacterial internalization.

On the other hand, for S. aureus internalization into bMECs, the MAPK pathway has a relevant role. When MAPK activity was blocked with pharmacological inhibitors of p38 (2.5–10 μM SB203580), JNK (5–20 μM, SP600125), or ERK1/2 (0.62–10 μM, U0126), a considerable reduction in S. aureus internalization was observed, indicating that these kinases are involved in this process [18]. Interestingly, LEAS inhibited the activation of MAPK p38 ~60% (Figure 4), suggesting that this kinase could have a relevant participation in the observed reduction of internalization. However, other approaches are necessary to determine the precise participation of p38 in this process.

Mastitis is an inflammation of the mammary gland caused principally by bacteria, which leads to the activation of the innate immune system [29]. TNF-α is a rapid-response proinflammatory cytokine expressed in bMECs and plays an important role in mastitis. Bacterial stimulation of bMECs induces the expression of TNF-α but is depending of the strain [30, 31]. bMECs challenged with S. aureus induced the expression of TNF-α up to 11-fold (data not shown), which coincides with the reported by our group [26]. However, bMECs treated with vehicle (DMSO 0.1%) and challenged 2 h with bacteria maintained the basal expression of the TNF-α mRNA (Table 3), which was attributable to the anti-inflammatory effects of DMSO, as reported in Caco-2 cells [32]. Noteworthy, LEAS (100 ng/ml) treatment decreased the expression of this cytokine 0.5-fold in bMECs, which was maintained even when cells were infected. This result is in accordance with a downregulation of TNF-α in pretreated bMECs with cholecalciferol (a lipid molecule) [19]. Also, we detected similar levels of TNF-α secretion in bMECs infected or pretreated with LEAS before the S. aureus challenge. However, the IL-1β secretion was induced in the infected LEAS-treated cells (Table 4) but not the mRNA expression of this gene. This effect can be the consequence of the activation of other mechanisms, such as inflammasome activation, which requires further research [33]. Interestingly, pretreated bMECs with LEAS showed an upregulation in IL-10 expression, which was more pronounced in bMECs challenged with bacteria (~20-fold). These results are attractive due to the fact that this cytokine is not significantly induced by S. aureus in the udder [34]. Interestingly, these anti-inflammatory effects of LEAS on bMECs (TNF-α downregulation and IL-10 upregulation) correlated with the decrease in the internalization of S. aureus into bMECs.

With regard to antimicrobial peptides, these molecules actively contribute to IIR by direct action against microbial infection and as a component of the inflammatory response [35]. It has been reported that bMECs express diverse antimicrobial peptides: among them are the β-defensins. During IIR of the bovine mammary gland against bacterial infections, it has been reported that the expression of β-defensin and bovine neutrophil defensin 5 (BNBD5) increases significantly [3, 26]. Similarly, BNBD5 is expressed in the bovine mammary gland, especially in bMECs, and its expression levels depend on the bacterial stimulus [36]. However, in pretreated bMECs with LEAS, the expression of BNBD5 was not modified; only when these cells were challenged with S. aureusan increase was observed (Table 3). Nevertheless, it is necessary to evaluate other antimicrobial peptides in future experiments in order to determine their contribution in the S. aureus internalization reduction induced by LEAS.

According to the results of this work, we propose that LEAS could be applied as a prophylactic treatment to avoid bovine intramammary infections, because they improve bMEC innate immune response.

5. Conclusions

The results of this work shown that lipid-rich extract from avocado (LEAS) is a modulator of innate immune response in bovine mammary epithelial cells during S. aureus infection. Also, LEAS (100 ng/ml) inhibits bacterial internalization into bMECs. These data suggest that LEAS could be useful for mastitis control.

Data Availability

The data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare no conflict of interest.

Acknowledgments

MBM was supported by a scholarship from CONACyT. This work was supported by grants from CONACyT (CB-2013-221363 and INFR-2014-230603) and CIC14.5 to JELM.

References

  1. N. Alva-Murillo, J. E. López-Meza, and A. Ochoa-Zarzosa, “Nonprofessional phagocytic cell receptors involved in Staphylococcus aureus internalization,” BioMed Research International, vol. 2014, Article ID 538546, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Oviedo-Boyso, J. J. Valdez-Alarcón, M. Cajero-Juárez et al., “Innate immune response of bovine mammary gland to pathogenic bacteria responsible for mastitis,” The Journal of Infection, vol. 54, no. 4, pp. 399–409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Ochoa-Zarzosa, E. Villarreal-Fernández, H. Cano-Camacho, and J. E. López-Meza, “Sodium butyrate inhibits Staphylococcus aureus internalization in bovine mammary epithelial cells and induces the expression of antimicrobial peptide genes,” Microbial Pathogenesis, vol. 47, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. I. K. Sundar and I. Rahman, “Vitamin D and susceptibility of chronic lung diseases: role of epigenetics,” Frontiers in Pharmacology, vol. 2, p. 50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. O. K. Dego, J. E. van Dijk, and H. Nederbragt, “Factors involved in the early pathogenesis of bovine Staphylococcus aureus mastitis with emphasis on bacterial adhesion and invasion. A review,” The Veterinary Quarterly, vol. 24, no. 4, pp. 181–198, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. S. L. Aitken, C. M. Corl, and L. M. Sordillo, “Immunopathology of mastitis: insights into disease recognition and resolution,” Journal of Mammary Gland Biology and Neoplasia, vol. 16, no. 4, pp. 291–304, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Fraunholz and B. Sinha, “Intracellular Staphylococcus aureus: live-in and let die,” Frontiers in Cellular and Infection Microbiology, vol. 2, p. 43, 2012. View at Publisher · View at Google Scholar
  8. N. Alva-Murillo, A. Ochoa-Zarzosa, and J. E. López-Meza, “Effects of sodium octanoate on innate immune response of mammary epithelial cells during Staphylococcus aureus internalization,” BioMed Research International, vol. 2013, Article ID 927643, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. D. Téllez-Pérez, N. Alva-Murillo, A. Ochoa-Zarzosa, and J. E. López-Meza, “Cholecalciferol (vitamin D) differentially regulates antimicrobial peptide expression in bovine mammary epithelial cells: implications during Staphylococcus aureus internalization,” Veterinary Microbiology, vol. 160, no. 1-2, pp. 91–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Dabas, R. Shegog, G. Ziegler, and J. Lambert, “Avocado (Persea americana) seed as a source of bioactive phytochemicals,” Current Pharmaceutical Design, vol. 19, no. 34, pp. 6133–6140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Y. Au, T. K. Al-Talib, A. Y. Au, P. V. Phan, and C. G. Frondoza, “Avocado soybean unsaponifiables (ASU) suppress TNF-α, IL-1β, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages,” Osteoarthritis and Cartilage, vol. 15, no. 11, pp. 1249–1255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. F. Heinecke, M. W. Grzanna, A. Y. Au, C. A. Mochal, A. Rashmir-Raven, and C. G. Frondoza, “Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate,” Osteoarthritis and Cartilage, vol. 18, no. 2, pp. 220–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Donnarumma, E. Buommino, A. Baroni et al., “Effects of AV119, a natural sugar from avocado, on Malassezia furfur invasiveness and on the expression of HBD-2 and cytokines in human keratinocytes,” Experimental Dermatology, vol. 16, no. 11, pp. 912–919, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. D’Ambrosio, C. Han, L. Pan, A. Douglas Kinghorn, and H. Ding, “Aliphatic acetogenin constituents of avocado fruits inhibit human oral cancer cell proliferation by targeting the EGFR/RAS/RAF/MEK/ERK1/2 pathway,” Biochemical and Biophysical Research Communications, vol. 409, no. 3, pp. 465–469, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. E. A. Lee, L. Angka, S. G. Rota et al., “Targeting mitochondria with Avocatin B induces selective leukemia cell death,” Cancer Research, vol. 75, no. 12, pp. 2478–2488, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Rosenblat, S. Meretski, J. Segal et al., “Polyhydroxylated fatty alcohols derived from avocado suppress inflammatory response and provide non-sunscreen protection against UV-induced damage in skin cells,” Archives of Dermatological Research, vol. 303, no. 4, pp. 239–246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. L. Anaya-López, O. E. Contreras-Guzmán, A. Cárabez-Trejo et al., “Invasive potential of bacterial isolates associated with subclinical bovine mastitis,” Research in Veterinary Science, vol. 81, no. 3, pp. 358–361, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Alva-Murillo, I. Medina-Estrada, M. Báez-Magaña, A. Ochoa-Zarzosa, and J. E. López-Meza, “The activation of the TLR2/p38 pathway by sodium butyrate in bovine mammary epithelial cells is involved in the reduction of Staphylococcus aureus internalization,” Molecular Immunology, vol. 68, no. 2, pp. 445–455, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Alva-Murillo, A. D. Téllez-Pérez, I. Medina-Estrada, C. Álvarez-Aguilar, A. Ochoa-Zarzosa, and J. E. López-Meza, “Modulation of the inflammatory response of bovine mammary epithelial cells by cholecalciferol (vitamin D) during Staphylococcus aureus internalization,” Microbial Pathogenesis, vol. 77, pp. 24–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. Tarpey and I. Fridovich, “Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite,” Circulation Research, vol. 89, no. 3, pp. 224–236, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. J. G. Kenny, D. Ward, E. Josefsson et al., “The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications,” PLoS One, vol. 4, no. 2, article e4344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. C. H. Chen, Y. Wang, T. Nakatsuji et al., “An innate bactericidal oleic acid effective against skin infection of methicillin-resistant Staphylococcus aureus: a therapy concordant with evolutionary medicine,” Journal of Microbiology and Biotechnology, vol. 21, no. 4, pp. 391–399, 2011. View at Google Scholar
  23. A. P. Desbois and K. C. Lawlor, “Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and Staphylococcus aureus,” Marine Drugs, vol. 11, no. 11, pp. 4544–4557, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Sun, Y. Hu, Z. Gu, R. T. Owens, Y. Q. Chen, and I. J. Edwards, “Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway,” Carcinogenesis, vol. 32, no. 10, pp. 1518–1524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. E. Rodriguez-Lopez, C. Hernandez-Brenes, and R. I. Diaz de la Garza, “A targeted metabolomics approach to characterize acetogenin profiles in avocado fruit (Persea americana Mill.),” RSC Advances, vol. 5, no. 128, pp. 106019–106029, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Alva-Murillo, A. Ochoa-Zarzosa, and J. E. López-Meza, “Short chain fatty acids (propionic and hexanoic) decrease Staphylococcus aureus internalization into bovine mammary epithelial cells and modulate antimicrobial peptide expression,” Veterinary Microbiology, vol. 155, no. 2-4, pp. 324–331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Medina-Estrada, J. E. López-Meza, and A. Ochoa-Zarzosa, “Anti-inflammatory and antimicrobial effects of estradiol in bovine mammary epithelial cells during Staphylococcus aureus internalization,” Mediators of Inflammation, vol. 2016, Article ID 6120509, 16 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. T. M. de Lima, L. de Sa Lima, C. Scavone, and R. Curi, “Fatty acid control of nitric oxide production by macrophages,” FEBS Letters, vol. 580, no. 13, pp. 3287–3295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. H. Schukken, J. Günther, J. Fitzpatrick et al., “Host-response patterns of intramammary infections in dairy cows,” Veterinary Immunology and Immunopathology, vol. 144, no. 3-4, pp. 270–289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Strandberg, C. Gray, T. Vuocolo, L. Donaldson, M. Broadway, and R. Tellam, “Lipopolysaccharide and lipoteichoic acid induce different innate immune responses in bovine mammary epithelial cells,” Cytokine, vol. 31, no. 1, pp. 72–86, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Zbinden, R. Stephan, S. Johler et al., “The inflammatory response of primary bovine mammary epithelial cells to Staphylococcus aureus strains is linked to the bacterial phenotype,” PLoS One, vol. 9, no. 1, article e87374, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Hollebeeck, T. Raas, N. Piront et al., “Dimethyl sulfoxide (DMSO) attenuates the inflammatory response in the in vitro intestinal Caco-2 cell model,” Toxicology Letters, vol. 206, no. 3, pp. 268–275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Breyne, S. K. Cool, D. Demon et al., “Non-classical proIL-1beta activation during mammary gland infection is pathogen-dependent but caspase-1 independent,” PLoS One, vol. 9, no. 8, article e105680, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. D. D. Bannerman, M. J. Paape, J.-W. Lee, X. Zhao, J. C. Hope, and P. Rainard, “Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 3, pp. 463–472, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Cormican, K. G. Meade, S. Cahalane et al., “Evolution, expression and effectiveness in a cluster of novel bovine β-defensins,” Immunogenetics, vol. 60, no. 3-4, pp. 147–156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Goldammer, H. Zerbe, A. Molenaar et al., “Mastitis increases mammary mRNA abundance of β-defensin 5, toll-like-receptor 2 (TLR2), and TLR4 but not TLR9 in cattle,” Clinical and Vaccine Immunology, vol. 11, no. 1, pp. 174–185, 2004. View at Publisher · View at Google Scholar · View at Scopus